胰島素受體(INSR)重組蛋白
Recombinant Insulin Receptor (INSR)
CD220; ISR; HHF5; IR
- 編號URPA895Hu06
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌
- 預(yù)測分子量56.9kDa
- 實際分子量60kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Pro622~Thr945 with His and TRxA Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)5.6
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 426 ¥ 1065 ¥ 2130 ¥ 6390 ¥ 15975
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPA895Hu01 | 胰島素受體(INSR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA895Hu05 | 胰島素受體(INSR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA895Hu02 | 胰島素受體(INSR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA895Hu03 | 胰島素受體(INSR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA895Hu06 | 胰島素受體(INSR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA895Hu04 | 胰島素受體(INSR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA895Hu01 | 胰島素受體(INSR)多克隆抗體 | WB; IHC; ICC/IF |
| UPAA895Hu03 | 胰島素受體(INSR)多克隆抗體 | WB; IHC; ICC/IF |
| UPAA895Hu02 | 胰島素受體(INSR)多克隆抗體 | WB; IHC; ICC/IF |
| ULAA895Hu81 | 胰島素受體(INSR)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| ULAA895Hu71 | 胰島素受體(INSR)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| UMAA895Hu22 | 胰島素受體(INSR)單克隆抗體 | WB; ICC/IF |
| UMAA895Hu24 | 胰島素受體(INSR)單克隆抗體 | WB; IHC |
| UMAA895Hu23 | 胰島素受體(INSR)單克隆抗體 | WB; IHC; ICC/IF |
| UMAA895Hu25 | 胰島素受體(INSR)單克隆抗體 | WB; IHC; ICC; IP. |
| UMAA895Hu27 | 胰島素受體(INSR)單克隆抗體 | WB; IHC |
| UMAA895Hu21 | 胰島素受體(INSR)單克隆抗體 | WB; IHC; ICC/IF |
| USEA895Hu | 胰島素受體(INSR)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| UAEA895Hu | 抗胰島素受體抗體(Anti-INSR)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antibody Detection. |
| ULMA895Hu | 胰島素受體(INSR)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSA895Hu11 | 胰島素受體(INSR)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| IOSR Journal of Applied Chemistry | Molecular and Biochemical Effect of Neem Extract On Experimental Diabetes [Org:Source] |
| Biol Pharm Bull | Age-Dependent Onset of Insulin Resistance in Insulin-Resistant Mice [PubMed: 26632184] |
| Nanomedicine | A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes [pubmed:27623396] |
| American Journal of Translational Research | Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β. [pubmed:28337257] |
| Biomedicine & Pharmacotherapy | Vitamin?D3?intake?as?regulator?of?insulin?degrading?enzyme?and?insulin?receptor?phosphorylationin?diabetic?rats. [pubmed:27930980] |
| Eur Neuropsychopharmacol. | Regulation of insulin receptor phosphorylation in the brains of prenatally stressed rats: New insight into the benefits of antidepressant drug treatment. [pubmed:28063625] |
| 臺灣農(nóng)業(yè)研究 | (臺灣農(nóng)業(yè)研究67 (4): 355-364) 香菇柄水萃物改善糖尿病降低阿茲海默氏癥罹病風(fēng)險初探 [] |
| Scientific Reports | Mechanism underlying starvation-dependent modulation of olfactory behavior in Drosophila larva [Pubmed: 32080342] |
| ADVANCED RESEARCHES | Prenatal Stress Induced Spatial Memory Deficit in a Sex-Specific Manner in Mice: Possible Involvement of Hippocampal Insulin Resistance [] |
| Current Biology | Internal State Affects Local Neuron Function in an Early Sensory Processing Center to Shape Olfactory Behavior in Drosophila Larvae [] |
留言咨詢
